Markets

Elmera posts 30% profit jump as Fortum takeover review continues
Norwegian energy group Elmera reported a 30% rise in second-quarter adjusted EBIT to NOK 121 million, while its debt fell sharply to NOK 1.04 billion amid an ongoing cash tender offer by Fortum.

Dax slips on weak tech cues, global equities pressure mounts
German benchmark index faces modest losses after semiconductor shares retreat in Asia and U.S. tech weakness. Heidelberger Druckmaschinen and Redcare Pharmacy diverge on earnings updates.

Goldman Sachs upgrades Japan’s top electronic component stocks on AI demand
Analysts at Goldman Sachs raise price targets and earnings forecasts for nine Japanese electronic component makers, citing surging AI server and data center demand. Ibiden, Murata and Taiyo Yuden highlighted for strongest margin and sales revisions.

Straumann names Christopher Norbye as next CEO, effective Dec 1
Guillaume Daniellot to step down after nearly 20 years, including seven as CEO. Norbye joins from Beijer Ref, where revenue doubled and profit tripled under his leadership.

Swiss SMI slips as 19 of 20 components fall; Geberit, DocMorris advance on earnings
The Swiss blue-chip index was set to open lower, with Geberit the sole gainer after strong half-year results. DocMorris surged 8% on earnings, while BKW dropped 3%. Global yields near multi-decade highs weighed on risk assets.

Complete Genomics appoints Lauren Selig to board ahead of Swiss Rockets deal
Selig joins as Swiss Rockets AG prepares to acquire the DNA sequencing firm, pending U.S. regulatory clearance. Her appointment reflects the deal's focus on precision healthcare and biotech innovation.

InterCure sets 1-for-5 reverse stock split for Aug. 24, 2026
The move aims to lift the share price above Nasdaq’s $1 minimum bid requirement. Trading will continue under the same ticker INCR.

Zaptec posts record Q2 revenue as EV charging orders surge 94%
Norwegian EV charging firm Zaptec reported a 32% revenue increase to 506 million NOK in Q2 2026, while order intake nearly doubled to 894 million NOK. EBITDA rose 57% to 69 million NOK as margins expanded.

Zaptec posts record Q2 2026 revenue, shares rise 0.3%
Norwegian EV charging firm Zaptec reported 506 million NOK in revenue, up 32% YoY, while order intake surged 94%. Shares edged up 0.32% to $47.50 in early trading.

Burckhardt Compression plans up to 220 job cuts in restructuring drive
Swiss compressor maker to slash up to 150 roles in Winterthur and 70 internationally, targeting annual savings of 20 million francs by 2026.

Straumann posts 7.8% organic revenue growth in H1, confirms 2026 outlook
Zahnimplantatehersteller Straumann reports 2.3% total revenue growth to CHF 1.38 billion in H1, with organic sales up 7.8%. CEO transition announced as Daniellot steps down after seven years.

Emmi posts 2.2% revenue rise in H1 2026, lifts annual outlook
Swiss dairy group Emmi reports stronger-than-expected first-half growth, with revenue up 2.2% to CHF 2.32bn, while maintaining full-year EBIT and net margin guidance.

KME plans Frankfurt IPO for copper-nickel unit Cunova worth up to $1.2 bln
Italian metals group KME has selected Berenberg and UniCredit to lead an IPO for its copper-nickel unit Cunova in Frankfurt, with a potential valuation of €1 billion. Listing could occur in 2026 or 2027.

Geberit lifts H1 sales on volumes, price hikes; shares surge 7%
Swiss sanitary products maker posts 2.8% reported net sales growth in first half, driven by higher volumes and pricing, while maintaining full-year guidance. Shares jump over 7% on strong Q2 beat.

Taiho and Cullinan to present lung cancer drug trial results at 2026 conference
Phase 3 REZILIENT3 trial of Zipalertinib plus chemotherapy met its primary endpoint in EGFR exon 20 insertion mutation-positive NSCLC patients. Results to be showcased at IASLC World Conference.

US stocks mixed pre-market; Moderna surges 100% on cancer therapy data
Moderna jumps 100% in premarket trading after data showed its personalized mRNA cancer vaccine combined with Merck’s Keytruda cut melanoma recurrence. SMI rises 0.36% as Lowe’s cuts guidance, Estee Lauder gains.

WiseTech Global shares plunge 11.5% after ACCC raid
Logistics software firm faces regulatory scrutiny as Australian watchdog demands documents related to global supply chain services. Shares hit session lows within minutes.

Leroy Seafood lifts wild-catch outlook despite Q2 earnings dip
Norway-based seafood producer raises full-year EBIT guidance for wild-catch segment to NOK 400-450 million on higher volumes and pricing, offsetting a 26% drop in Q2 operational EBIT.

EUR/USD breakout tests dollar’s yield-driven support amid Treasury buybacks
Dollar weakens after U.S. Treasury doubles long-end bond buybacks to $4bn, narrowing yield spreads with Germany. EUR/USD eyes 1.1785 after breaking above 200-day average.

Zaptec posts record Q2 revenue, order intake surges 94%
Norwegian EV charging firm reports 32% revenue growth and a 97% jump in order backlog. Europe’s top AC charging provider expands production as plug-in vehicle sales rise.

Desert Control sees 500% jump in pilot projects, lifts 2026 revenue target
The agritech firm raised its full-year revenue guidance to $2 million, citing a surge in Tier 1 pilots and a $56 million potential pipeline. Stock remains near 52-week lows.

Kuaishou Q2 profit steady as stock slides 4% on margin pressure
Revenue rose 1.4% year-over-year to 35.5 billion yuan, but gross margin narrowed to 51.6% as costs climbed. Kling AI revenue tripled to over 850 million yuan.

Shanghai cuts mortgage down payment to 15% to revive housing demand
City reduces minimum down payment for second homes and offers subsidies up to 80,000 yuan as authorities roll out fresh measures to stabilize the property market.

Moderna, Merck melanoma vaccine trial succeeds in late-stage study
Interim results show mRNA-based therapy cuts recurrence risk in high-risk patients. Moderna shares jump 60% in premarket trading.

Why the Swiss Franc Is Poised to Re‑Emerge as the Go‑To Funding Currency
After a rare yen intervention, traders are eyeing the franc’s zero‑rate environment as the next cheap carry, a shift that could reshape EUR/CHF and USD/CHF dynamics.

